NSEReply to Clarification- Financial results10 Jul 2026 · 10 Jul 2026, 04:14 pm
Reply to Clarification- Financial results
Gujarat Kidney And Super Speciality Limited · GKSL
✦ AI SummaryResults
Gujarat Kidney And Super Speciality Limited has clarified a deficiency observation in its financial results for the quarter ended 31-Mar-2026, stating that the date mentioned for signing of the standalone financial statements was incorrect due to a typographical error. The company has undertaken to publish the corrected financial statements on its website and assured the exchange of its continued compliance with SEBI LODR Regulations.
Analysis Scores
Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
The Exchange had sought clarification from Gujarat Kidney And Super Speciality Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: The response of the Company is enclosed.
Attachments (1)
📄pdf
Download →
GKSL2025_27062026180528_Final_Corrected_Financial.pdf
View document text
Date: 26/06/2026
National Stock Exchange of India Limited
Listing Department “Exchange Plaza,”
C-1, Block – G, Bandra – Kurla Complex,
Bandra (E), Mumbai 400 051
Sub: Reply to your email dated 25/06/2026 seeking Clarification for Financial
results - Deficiency Observation – Financial Results submitted on 28-May-2026
We refer to the above-mentioned communication wherein it has been observed that the
date mentioned for signing of the Standalone Financial Statements (SFS) is incorrect and
not in conformity with the format prescribed under SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015.
In this regard, we wish to submit the following clarification:
1. Nature of Error: The incorrect date mentioned in the Standalone Financial Statements
is purely a typographical/clerical error. The actual date of signing of the Standalone
Financial Statements by the authorised signatories was 28-May-2025.
2. Corrective Action: We hereby undertake to publish the corrected Standalone Financial
Statements with the accurate signing date on the website of Gujarat Kidney and Super
Speciality Limited at www.gujaratsuperspecialityhospital.com. The corrected document
shall be uploaded at the earliest.
3. Undertaking: We confirm that this error was inadvertent and has no bearing on the
financial figures, disclosures, or substance of the financial results. Appropriate internal
checks shall be put in place to avoid recurrence of such typographical errors in future
submissions.
We regret the inconvenience caused due to this inadvertent error and assure the Exchange
of our continued compliance with the applicable SEBI LODR Regulations. We are enclosing
the corrected copy of the Standalone Financial Statements.
Thanking you,
Yours faithfully,
For Gujarat Kidney and Super Speciality Limited
Dr Pragnesh Bharpoda
Managing Director
DIN:01033141